β€’
Mar 31, 2020

Johnson & Johnson Q1 2020 Earnings Report

Johnson & Johnson reported strong growth in sales and EPS despite the negative impact of the COVID-19 pandemic.

Key Takeaways

Johnson & Johnson reported a strong first quarter with sales of $20.7 billion, reflecting a 3.3% increase. EPS increased by 56.1% to $2.17, and adjusted EPS increased by 9.5% to $2.30. The company also announced a 6.3% increase in the quarterly dividend.

Sales reached $20.7 billion, with a growth of 3.3%.

EPS increased 56.1% to $2.17.

Adjusted EPS increased 9.5% to $2.30.

Quarterly dividend increased by 6.3%.

Total Revenue
$20.7B
Previous year: $20B
+3.3%
EPS
$2.3
Previous year: $2.1
+9.5%
Gross Profit
$13.6B
Previous year: $13.4B
+1.7%
Cash and Equivalents
$15.5B
Previous year: $14.7B
+5.4%
Free Cash Flow
$2.73B
Previous year: $2.89B
-5.3%
Total Assets
$155B
Previous year: $150B
+3.3%

Johnson & Johnson

Johnson & Johnson

Forward Guidance

Johnson & Johnson lowered its 2020 guidance to reflect the impact of COVID-19 and related investments.